Hoffman Robert E.
CIK 0001166288
President, CEO, and CFODirector
Filings
12
Latest Jun 1, 2026
Issuers covered
4
Showing
12 of 12
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -22.7% | -22.7% | -22.7% | -22.7% |
| 90 days | 1 | 0% | -65.0% | -65.0% | -65.0% | -65.0% |
| 180 days | 1 | 0% | -60.1% | -60.1% | -60.1% | -60.1% |
| 365 days | 1 | 0% | -74.0% | -74.0% | -74.0% | -74.0% |
Issuers
Companies where Hoffman Robert E. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KTRA | Kintara Therapeutics, Inc. | 5 | Feb 17, 2026 |
| ESPR | Esperion Therapeutics, Inc. | 3 | Jun 1, 2026 |
| CYDY | Cytodyn Inc. | 2 | Mar 24, 2026 |
| FBLG | Fibrobiologics, Inc. | 2 | Jun 12, 2025 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|